US Stem Cell Inc (USRM)

[Dragon Lady]

Quote: "For anyone that wants to do some DD on BioHeart. I would suggest reading all the archived PR from the last 2 years. If you start from two years ago and work your way to the last PR you'll see the business plan unfold perfectly. IMO"

PR as a source of info and especially "due diligence" about a public traded company?

If anyone wants to do their due diligence (DD in the quote above)- I'd suggest going back as far as one wants, all the way to 2008 when BHRT first bean trading as a public company and reading cover to cover every SEC filing BHRT has ever posted/reported to the SEC.

If you read those, starting 2 yrs ago, 1 yr ago or better yet all the way to 2008/2009, I think you'll see the true condition of the business, any business "plan" (they change nearly constantly IMO, one will find via reading SEC filings) an see the true financial condition (also things like massive, massive common share dilution) as it's actually unfolded- including how many of the "PR" just never actually came true. Perfectly IMO.

All the SEC filings are found here on the SEC (U.S. Federal govt Securities and Exchange Commission maintained site, the main regulatory body for all U.S. public traded stock markets)- every last one:

http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001388319&owner=exclude&count=40&hidefilings=0

Here's just a couple of "PR" that were part of the "business plan" - try and find um later in the SEC filings to see what happened to those great sounding "PR" and "plans" and all (just as a couple of random examples):

http://www.marketwired.com/press-release/northstar-launches-20-million-private-placement-round-with-proceeds-fund-bioheart-trials-otcqb-bhrt-1713163.htm

http://www.marketwired.com/press-release/bioheart-receives-2-million-term-sheet-investment-offer-from-vitalmex-global-leader-otcbb-bhrt-1686526.htm

http://www.marketwired.com/press-release/bioheart-announces-phase-iii-mirror-trial-for-myocell-initiated-otcqb-bhrt-1807938.htm

http://www.bizjournals.com/southflorida/stories/2010/07/26/daily1.html

http://www.prnewswire.com/news-releases/bioheart-announces-cell-therapies-program-in-the-middle-east-for-congestive-heart-failure-and-peripheral-arterial-disease-patients-95110334.html

Those are some good "PR" IMO to compare to the SEC filings later- to see how the "plan" turned out in reality.

I'd personally, if it was me, read the SEC filings over any "PR", but that's just me. IMO, the SEC created the entire concept of having public traded companies be required to present "SEC FILINGS" (10-K, 10-Q, etc) as the way for the investing public to do "due diligence" versus only having company "PR" available. Notice, the SEC isn't interested in what's said in "PR", the SEC wants formal, SEC filings that are signed off by the company's most Sr. Mgt and company officers. I personally think the SEC evolved this system of reporting over the years for the very reason that "PR" nearly always "sounds good" but SEC filings give a whole lot more required info.

My 2 cents.